Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
Alejandro Romero, Eva Ramos, Francisco López‐Muñoz, et al.
Cellular and Molecular Neurobiology (2020) Vol. 42, Iss. 3, pp. 489-500
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation
Kiandokht Keyhanian, Raffaella Pizzolato Umeton, Babak Mohit, et al.
Journal of Neuroimmunology (2020) Vol. 350, pp. 577436-577436
Open Access | Times Cited: 140
Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
Daniel P. Cardinali, Gregory M. Brown, Seithikurippu R. Pandi‐Perumal
Diseases (2020) Vol. 8, Iss. 4, pp. 44-44
Open Access | Times Cited: 79
Molecular Mechanisms of Melatonin-Mediated Cell Protection and Signaling in Health and Disease
Dalia M. Kopustinskienė, Jurga Bernatonienė
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 129-129
Open Access | Times Cited: 68
Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review
Elnaz Khani, Sajad Khiali, Samineh Beheshtirouy, et al.
European Journal of Pharmacology (2021) Vol. 912, pp. 174582-174582
Open Access | Times Cited: 59
Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action
Ana Muñoz-Jurado, Begoña M. Escribano, Javier Caballero‐Villarraso, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1569-1596
Open Access | Times Cited: 58
The neurobiology of SARS-CoV-2 infection
Jenny Meinhardt, Simon Streit, Carsten Dittmayer, et al.
Nature reviews. Neuroscience (2023) Vol. 25, Iss. 1, pp. 30-42
Closed Access | Times Cited: 37
Food policy, nutrition and nutraceuticals in the prevention and management of COVID-19: Advice for healthcare professionals
Yasemin Ipek Ayseli, Nazli Aytekin, Derya Büyükkayhan, et al.
Trends in Food Science & Technology (2020) Vol. 105, pp. 186-199
Open Access | Times Cited: 57
Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19
Dun‐Xian Tan, Rüdiger Hardeland
Molecules (2020) Vol. 25, Iss. 19, pp. 4410-4410
Open Access | Times Cited: 55
A Review of the Role of Micronutrients and Bioactive Compounds on Immune System Supporting to Fight against the COVID-19 Disease
Montaña Cámara, María de Cortes Sánchez‐Mata, Virginia Fernández-Ruíz, et al.
Foods (2021) Vol. 10, Iss. 5, pp. 1088-1088
Open Access | Times Cited: 48
Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions
Ludmila Müller, Svetlana Di Benedetto
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
Erika Cecon, Daniela Fernandois, Nicolas Renault, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Open Access | Times Cited: 24
A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review)
Ioannis Lempesis, Vasiliki Georgakopoulou, Russel J. Reıter, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 3
Open Access | Times Cited: 5
Role of Melatonin on Virus-Induced Neuropathogenesis—A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection
Prapimpun Wongchitrat, Mayuri Shukla, Ramaswamy Sharma, et al.
Antioxidants (2021) Vol. 10, Iss. 1, pp. 47-47
Open Access | Times Cited: 30
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy
Eva Ramos, Francisco López‐Muñoz, Emilio Gil‐Martín, et al.
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1152-1152
Open Access | Times Cited: 24
Evaluation of the effect of melatonin on patients with COVID-19 admitted to ICU: A double-blind randomized clinical trial
Mahmoud Ganjifard, Shokouh Ghafari, Adeleh Sahebnasagh, et al.
Vacunas (English Edition) (2025) Vol. 26, Iss. 1, pp. 100377-100377
Closed Access
New Proposal Involving Nanoformulated Melatonin Targeted to The Mitochondria as A Potential COVID-19 Treatment
Virna Margarita Martín Giménez, Natalia Jorgelina Prado, Emiliano Diez, et al.
Nanomedicine (2020) Vol. 15, Iss. 29, pp. 2819-2821
Open Access | Times Cited: 27
Cumulative Protective Effect of Melatonin and Indole-3-Propionic Acid against KIO3—Induced Lipid Peroxidation in Porcine Thyroid
Paulina Iwan, Jan Stępniak, Małgorzata Karbownik‐Lewińska
Toxics (2021) Vol. 9, Iss. 5, pp. 89-89
Open Access | Times Cited: 20
Sleep and Long COVID—A Review and Exploration of Sleep Disturbances in Post Acute Sequelae of SARS-COV-2 (PASC) and Therapeutic Possibilities
Elliott K. Lee, R. Robert Auger
Current Sleep Medicine Reports (2024) Vol. 10, Iss. 2, pp. 169-180
Closed Access | Times Cited: 2
Presence of melatonin in foods of daily consumption: The benefit of this hormone for health
Ana Muñoz-Jurado, Begoña M. Escribano
Food Chemistry (2024) Vol. 458, pp. 140172-140172
Open Access | Times Cited: 2
Unlocking the health benefits of melatonin supplementation: A promising preventative and therapeutic strategy
Firas S. Azzeh, Waad W. Kamfar, Mazen M. Ghaith, et al.
Medicine (2024) Vol. 103, Iss. 38, pp. e39657-e39657
Open Access | Times Cited: 2
Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2
Rahima Begum, A. N. M. Mamun-Or-Rashid, Tanzima Tarannum Lucy, et al.
Molecules (2022) Vol. 27, Iss. 20, pp. 6934-6934
Open Access | Times Cited: 11
Effects of COVID-19 on Synaptic and Neuronal Degeneration
Mohammed S. Alqahtani, Mohamed Abbas, Mohammad Y. Alshahrani, et al.
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 131-131
Open Access | Times Cited: 5
Management of Anosmia in COVID-19: A Comprehensive Review
Khushi Khurana, C. Singh
Cureus (2022)
Open Access | Times Cited: 8
SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19
Ana Muñoz-Jurado, Begoña M. Escribano, Eduardo Agüera, et al.
Journal of Neurology (2022) Vol. 269, Iss. 9, pp. 4581-4603
Open Access | Times Cited: 7
Pharmacotherapy of Mental Disorders Associated with COVID-19
Олена Хаустова, Oleh Chaban
Психиатрия психотерапия и клиническая психология (2021), Iss. 1, pp. 85-105
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top